The Hidden Toll of Drug Price Controls: Fewer New Treatments and Higher Medical Costs for the World

When nations implement pharmaceutical price controls, they reduce pharmaceutical revenues, which then reduces investments in further R&D, limiting future generations’ access to new novel treatments needed to fight diseases such as cancer, Alzheimer’s, heart disease, and diabetes.

Many countries are willing to sacrifice economic welfare by paying higher energy prices to save the planet from climate change. Yet, when it comes to curing diseases, they free ride on the investments of others.